|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oversikt over luftvegsprøver, Mikrobiologisk
avdeling, HUS. |
2020-2021 |
|
|
Inneliggjande pasientar |
Veke 21-26 |
|
Veke 21-25 |
|
Veke 21-24 |
|
Veke 21-23 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
128 |
<5 |
|
|
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
|
Bordetella parapertussis |
128 |
<5 |
|
|
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
|
Mycoplasma pneumoniae |
128 |
<5 |
|
|
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
|
Chlamydia pneumoniae |
128 |
<5 |
|
|
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
|
Influensavirus A |
362 |
<5 |
|
|
334 |
<5 |
|
|
368 |
<5 |
|
|
296 |
<5 |
|
|
|
Influensavirus B |
362 |
<5 |
|
|
334 |
<5 |
|
|
368 |
<5 |
|
|
296 |
<5 |
|
|
|
Parainfluensavirus 1 |
128 |
<5 |
|
|
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
|
Parainfluensavirus 2 |
128 |
<5 |
|
|
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
|
Parainfluensavirus 3 |
128 |
<5 |
|
|
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
|
Respiratorisk syncytialt virus |
207 |
<5 |
|
|
224 |
<5 |
|
|
233 |
<5 |
|
|
203 |
<5 |
|
|
|
Humant metapneumovirus |
128 |
<5 |
|
|
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
|
Rhinovirus |
128 |
13 |
10 % |
|
113 |
9 |
8 % |
|
105 |
12 |
11 % |
|
94 |
11 |
12 % |
|
|
SARS-CoV-2 |
436 |
<5 |
|
|
400 |
<5 |
|
|
453 |
<5 |
|
|
364 |
<5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ambulante pasientar |
Veke 21-26 |
|
Veke 21-25 |
|
Veke 21-24 |
|
Veke 21-23 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
130 |
<5 |
|
|
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
|
Bordetella parapertussis |
130 |
<5 |
|
|
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
|
Mycoplasma pneumoniae |
130 |
<5 |
|
|
173 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
|
Chlamydia pneumoniae |
130 |
<5 |
|
|
173 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
|
Influensavirus A |
136 |
<5 |
|
|
183 |
<5 |
|
|
145 |
<5 |
|
|
164 |
<5 |
|
|
|
Influensavirus B |
136 |
<5 |
|
|
183 |
<5 |
|
|
145 |
<5 |
|
|
164 |
<5 |
|
|
|
Parainfluensavirus 1 |
130 |
<5 |
|
|
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
|
Parainfluensavirus 2 |
130 |
<5 |
|
|
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
|
Parainfluensavirus 3 |
130 |
<5 |
|
|
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
|
Respiratorisk syncytialt virus |
132 |
<5 |
|
|
179 |
<5 |
|
|
146 |
<5 |
|
|
158 |
<5 |
|
|
|
Humant metapneumovirus |
130 |
<5 |
|
|
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
|
Rhinovirus |
130 |
44 |
34 % |
|
172 |
43 |
25 % |
|
144 |
42 |
29 % |
|
151 |
45 |
30 % |
|
|
SARS-CoV-2 |
9682 |
32 |
0 % |
|
10054 |
20 |
0 % |
|
10008 |
46 |
0 % |
|
9007 |
55 |
1 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inneliggjande pasientar omfatter fleire
sjukehus i vår region |
|
|
|
|
|
|
|
07.07.2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|